abstract |
The present invention relates to a method for treating multiple sclerosis, particularly relapsing multiple sclerosis. A method for treating a patient suffering from multiple sclerosis, particularly relapsing multiple sclerosis, wherein a pharmaceutical composition comprising a therapeutically effective amount of oligonucleotide 1 is routinely administered to the patient. Administration and thereby treating the patient. [Selection figure] None |